Mental Health AI Chatbots as Pharmakon: A Tripartite Theory of Use despite Risk
Psychotherapy and Psychosomatics · 02.04.2026 · 1-5
DOI: 10.1159/000551841 ↗Kurz gefasst
Leserbrief in der Zeitschrift Psychotherapy and Psychosomatics, online erschienen am 02.04.2026. Verfasst von Anthony P Weiss und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA, aweiss3@bidmc.harvard.edu. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA, aweiss3@bidmc.harvard.edu.
- Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA, aweiss3@bidmc.harvard.edu.
- Center for Bioethics, Harvard Medical School, Boston, Massachusetts, USA, aweiss3@bidmc.harvard.edu.
- Department of Psychiatry, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
- Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.
Zitieren
APA
Weiss, A. P., Keshvan, M., & Torous, J. (2026). Mental Health AI Chatbots as Pharmakon: A Tripartite Theory of Use despite Risk. Psychotherapy and Psychosomatics, 1-5. https://doi.org/10.1159/000551841
Vancouver
Weiss AP, Keshvan M, Torous J. Mental Health AI Chatbots as Pharmakon: A Tripartite Theory of Use despite Risk. Psychotherapy and Psychosomatics. 2026:1-5. doi:10.1159/000551841
BibTeX
@article{Weiss2026,
author = {Weiss, Anthony P and Keshvan, Matcheri and Torous, John},
title = {Mental Health AI Chatbots as Pharmakon: A Tripartite Theory of Use despite Risk},
journal = {Psychotherapy and Psychosomatics},
year = {2026},
pages = {1--5},
doi = {10.1159/000551841}
}
EUVIMED